Diametric Capital’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-106,031
Closed -$798K – 418
2024
Q1
$798K Buy
+106,031
New +$968K 0.44% 58
2023
Q2
– Sell
-23,338
Closed -$272K – 401
2023
Q1
$272K Buy
+23,338
New +$298K 0.13% 202

Other funds holding HCAT

Diametric Capital's HCAT Position: Q2 2024 in Review

Diametric Capital sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 106,031 shares — an estimated $798K sold.

Diametric Capital first reported a position in HCAT in Q1 2023 and held it in 2 quarters. The position peaked at $798K in Q1 2024. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Diametric Capital reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Diametric Capital sold 106,031 Health Catalyst shares in Q2 2024, an estimated $798K.
  • Diametric Capital first reported a position in Health Catalyst in Q1 2023 and held it in 2 quarters.
  • Diametric Capital's Health Catalyst position peaked at $798K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Diametric Capital's 13F filing for Q2 2024, filed 13 Aug 2024.